These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24033257)

  • 21. Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.
    Savory N; Abe K; Sode K; Ikebukuro K
    Biosens Bioelectron; 2010 Dec; 26(4):1386-91. PubMed ID: 20692149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of structure-switching in the design of aptamer biosensors.
    Lau PS; Li Y
    Adv Biochem Eng Biotechnol; 2014; 140():69-92. PubMed ID: 23851586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selecting and affinity analysis of DNA aptamers to MPT64 protein from Mycobacterium tuberculosis].
    Qin LH; Ma ZZ; Zheng RJ; Liu ZH; Lu JM; Hu ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):453-8. PubMed ID: 19031807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in aptamer screening and small molecule aptasensors.
    Kim YS; Gu MB
    Adv Biochem Eng Biotechnol; 2014; 140():29-67. PubMed ID: 23851587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.
    König J; Julius C; Baumann S; Homann M; Göringer HU; Feldbrügge M
    RNA; 2007 Apr; 13(4):614-22. PubMed ID: 17283213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target replacement strategy for selection of DNA aptamers against the Fc region of mouse IgG.
    Ma J; Wang MG; Mao AH; Zeng JY; Liu YQ; Wang XQ; Ma J; Tian YJ; Ma N; Yang N; Wang L; Liao SQ
    Genet Mol Res; 2013 Apr; 12(2):1399-410. PubMed ID: 23661463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing cross-reactivity with evolutionary search for sensors.
    Yang KA; Pei R; Stefanovic D; Stojanovic MN
    J Am Chem Soc; 2012 Jan; 134(3):1642-7. PubMed ID: 22142383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aptamers: characteristics and applications in pathogenic microorganism].
    Liang H; Yang S; Zhang T; Hu G; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):698-703. PubMed ID: 21845835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aptamer-modified nanoparticles as biosensors.
    Lönne M; Zhu G; Stahl F; Walter JG
    Adv Biochem Eng Biotechnol; 2014; 140():121-54. PubMed ID: 23824145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selection and identification of DNA aptamers against DC-SIGN].
    Chen F; Zeng J; Sun P; Pan Q; Zhang XL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1133-6. PubMed ID: 19068192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro selection of ssDNA aptamers using biotinylated target proteins.
    Mayer G; Höver T
    Methods Mol Biol; 2009; 535():19-32. PubMed ID: 19377986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in binder identification and characterisation: the case of oligonucleotide aptamers.
    Taouji S; Dausse E; Evadé L; Di Primo C; Toulmé JJ; Chevet E
    N Biotechnol; 2012 Jun; 29(5):550-4. PubMed ID: 22178698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerating Post-SELEX Aptamer Engineering Using Exonuclease Digestion.
    Canoura J; Yu H; Alkhamis O; Roncancio D; Farhana R; Xiao Y
    J Am Chem Soc; 2021 Jan; 143(2):805-816. PubMed ID: 33378616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Array-based discovery of aptamer pairs.
    Cho M; Oh SS; Nie J; Stewart R; Radeke MJ; Eisenstein M; Coffey PJ; Thomson JA; Soh HT
    Anal Chem; 2015 Jan; 87(1):821-8. PubMed ID: 25495696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamers: current challenges and future prospects.
    Rozenblum GT; Lopez VG; Vitullo AD; Radrizzani M
    Expert Opin Drug Discov; 2016; 11(2):127-35. PubMed ID: 26630462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution and protein packaging of small-molecule RNA aptamers.
    Lau JL; Baksh MM; Fiedler JD; Brown SD; Kussrow A; Bornhop DJ; Ordoukhanian P; Finn MG
    ACS Nano; 2011 Oct; 5(10):7722-9. PubMed ID: 21899290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of aptamers for molecular recognition and characterization of cancer cells.
    Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
    Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
    Mahlknecht G; Sela M; Yarden Y
    Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-based Capture-SELEX for the selection of small molecule-binding aptamers.
    Boussebayle A; Groher F; Suess B
    Methods; 2019 May; 161():10-15. PubMed ID: 30953759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.